Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions
Georges Mjaess, Laura Haddad, Teddy Jabbour, Arthur Baudewyns, Henri-Alexandre Bourgeno, Yolène Lefebvre, Mariaconsiglia Ferriero, Giuseppe Simone, Alexandre Fourcade, Georges Fournier, Marco Oderda, Paolo Gontero, Adrián Bernal-Gómez, Alessandro Mastrorosa, Jean-Baptiste Roche, Rawad Abou Zahr, Guillaume Ploussard, G. Fiard, Adam Haliński, Kateřina Ryšánková, Charles Dariane, Gina Delavar, J. Anract, Nicolas Barry Delongchamps, Alexandre Patrick Bui, Fayek Taha, Olivier Windisch, Daniel Benamran, G. Assenmacher, Jan Benijts, Karsten Guenzel, Thierry Roumeguère, Alexandre Peltier, Romain Diamand
Topics & Concepts
MedicineProstate cancerProstateRisk stratificationProstate-specific antigenMagnetic resonance imagingBiopsyRadiologyOncologyUrologyInternal medicineCancerProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchUrologic and reproductive health conditions